DOCS
DOXIMITY-A (DOCS)
NYSE
$25.45+$0.12 (+0.47%)
Price as of Aug 21, 2026 7:59 PM EDT
  • $3.2B
    Market Cap
  • -62.61%
    1-Year Change
  • Health Information Services
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 71
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

What Investors Should Know of This Doximity Officer's Latest Insider Transaction

Doximity's Chief Accounting Officer Siddharth Sitaram sold 5,652 shares worth $140,400 in mid-August. The transaction was driven by routine tax obligations from option exercises and restricted stock unit vesting rather than a loss of confidence in the company. Sitaram retains significant equity holdings of 93,122 shares. The sale reflects standard tax-driven liquidity management common among executives.

08/18/2026, 6:31 AMThe Motley Fool

Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors

Doximity's president Steven Zatz sold 4,482 shares worth $111,154 on August 15 through a routine tax withholding transaction upon restricted stock unit vesting. Zatz retains 51,864 directly held shares valued at $1.29 million, but his significant upside exposure comes from 150,000 options granted in July with a $20.49 strike price that don't vest until July 2027. The timing is notable given Doximity's recent earnings showed 7% revenue growth but margin compression due to higher-than-expected AI compute costs, with the CFO characterizing this as a 'good problem' as AI search revenue recognition is expected in Q3.

08/18/2026, 6:24 AMThe Motley Fool

Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.

Doximity's new CFO Matthew Sonefeldt sold 15,311 shares worth $380,000 in a non-discretionary transaction tied to restricted stock unit vesting and tax obligations. The sale reduced his holdings by only 3%, leaving him with a $12.1 million equity stake. The filing comes as the company faces slowing growth with Q3 guidance at only 1% growth midpoint, tight pharma spending, and margin pressure from AI compute costs, though management expects improvement in Q3 when AI search revenue lands.

08/18/2026, 6:16 AMThe Motley Fool

Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About?

Doximity CEO Jeffrey Tangney sold 8,505 shares (~$211,000) on August 15 to cover tax withholding on vesting equity awards—a non-discretionary transaction that reduced his holdings by only 0.3%. While the insider transaction itself is unremarkable, the underlying business faces headwinds: Q1 revenue grew just 7%, gross margins compressed due to AI compute costs, adjusted EBITDA fell 6%, and net income dropped significantly. The stock has cratered over 60% in the past year as the company invests heavily in AI with revenue recognition delayed until Q3.

08/18/2026, 6:11 AMThe Motley Fool

Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup

Atlassian and Doximity surged over 30% after earnings by exceeding low expectations with strong AI adoption. Three similar SaaS stocks—GitLab, UiPath, and Asana—have comparable setups with low expectations, high short interest, and emerging AI solutions that could drive significant post-earnings gains.

08/11/2026, 1:29 PMThe Motley Fool

Why Doximity Stock Skyrocketed on Friday

Doximity shares surged 32.62% after management revealed strong returns on AI investments. The company's AI assistant, Doximity Ask, topped independent clinical AI model rankings with the lowest error rates. Management highlighted that AI Search generates over 10x revenue compared to operational costs, with AI prompt volume up 25% quarter-over-quarter and AI Scribe users growing 10x year-over-year.

08/08/2026, 1:06 PMThe Motley Fool

Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale?

Doximity stock has plummeted 56% in 2026 amid concerns that AI could disrupt its medical platform services. However, the author argues these fears are overblown, citing the company's dominant 85%+ physician network, strong customer base (top 20 pharma companies and hospital systems), and regulatory barriers that protect it from easy disruption. Trading at 15x free cash flow, the author views it as a buying opportunity as pharma advertising spending should eventually rebound.

05/24/2026, 12:30 PMThe Motley Fool

Dow Jones Rally Looks Fragile With Inflation Data Running Hot

The Dow Jones climbed back above 50,000 driven by Cisco's strong earnings beat and guidance raise, while Nvidia gained on news of Chinese H200 chip approvals. However, the rally appears fragile as inflation data runs hot with import prices spiking 1.9% and energy costs surging, offsetting positive consumer resilience metrics. The Trump-Xi summit in Beijing provided mild sentiment support but delivered limited concrete deliverables.

05/14/2026, 12:54 PMInvesting

Why Doximity Stock Plunged Today

Doximity stock fell 24% after reporting mixed Q4 2026 earnings with only 5% sales growth and disappointing 2027 guidance of 3-5% revenue growth. The company is increasing AI spending amid a soft healthcare advertising market, pressuring profitability. Despite industry headwinds, Doximity maintains its market leadership with 85% of U.S. physicians on its platform and trades at a cheap 12x forward earnings valuation.

05/14/2026, 11:03 AMThe Motley Fool

Stock Market Today: S&P 500, Dow, Nasdaq Futures Gain As Trump Clears NVDA's H200 Sales To China— Cisco Systems, Doximity In Focus (UPDATED)

U.S. stock futures rose on Thursday as President Trump addresses trade issues with China. Cisco Systems surged 18.8% on better-than-expected Q3 results and raised FY26 guidance. Doximity plunged 21.46% on mixed Q4 results and weak guidance. Grocery Outlet gained 16.41% after beating EPS estimates by 150%. The Fed is expected to hold rates steady in June with 98.6% probability. Nvidia's H200 chip sales to Chinese firms were cleared by the U.S., though Beijing halted deliveries.

05/14/2026, 8:55 AMBenzinga

Stock Market Today: S&P 500, Dow Jones Futures Gain As Trump Clears NVDA's H200 Sales To China—Cisco Systems, Doximity, Grocery Outlet In Focus

U.S. stock futures rose on Thursday as President Trump addresses trade issues with China. Cisco Systems surged 18.8% on better-than-expected Q3 results and raised FY26 guidance. Doximity plunged 21.46% on mixed Q4 results and weak guidance. Grocery Outlet gained 16.41% after beating EPS estimates by 150%. The Fed is expected to hold rates steady in June with 98.6% probability. Treasury yields remain elevated at 4.46% (10-year) and 3.97% (2-year).

05/14/2026, 5:11 AMBenzinga

Stock Market Today: Nasdaq 100 Rises Despite Hot PPI, Nvidia Hits Record High

Tech stocks surged on Wednesday despite a hotter-than-expected April PPI reading (6% YoY vs 4.8% expected), which rekindled inflation concerns. The Nasdaq 100 gained 0.7% led by semiconductor strength, while rate-sensitive sectors like utilities and financials declined. Nvidia hit record highs above $226 ahead of earnings, Ford surged 11.9% on strong Q1 results, and software stocks like Dynatrace and Doximity fell sharply on disappointing earnings.

05/13/2026, 1:38 PMBenzinga

S&P 500 Valuation Looks Stretched as Inflation Reprices Rate-Cut Odds

Hot inflation data (April PPI up 1.4% vs 0.5% consensus) has forced markets to reprice lower rate-cut expectations, pressuring equities and extending Treasury yields to 4.475%. While semiconductor stocks rallied on Trump's Beijing summit and memory pricing strength, the broader market faces stretched valuations with asymmetric earnings reaction patterns favoring misses over beats. Kevin Warsh is set to become Fed chair amid the worst macro moment for establishing credibility.

05/13/2026, 12:22 PMInvesting

Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight.

Doximity (DOCS), a social network and software platform for doctors, has fallen 66% over the past year amid software stock selloffs driven by AI disruption fears. Despite the stock decline, the underlying business remains strong with 89.75% gross margins, 38.5% EBIT margins, and a dominant position serving 85% of U.S. physicians. Trading at a P/E of 21, the stock presents a buying opportunity for investors as the company expands into new software tools like DoxGPT.

02/23/2026, 1:15 AMThe Motley Fool

Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC is investigating whether officers and directors of Doximity Inc. breached their fiduciary duties to shareholders. The firm is seeking long-term shareholders to participate in potential litigation for corporate governance reforms and financial recovery.

02/12/2026, 1:00 PMGlobeNewswire

Peers

Statistics

More
Day Range
$25.12
$25.87
$25.33
1-Year Range
$18.01
$75.12
$25.33
Latest Close$25.33
Change
-$0.61 (-2.41%)
Volume2,676,850
Market Cap$3.2B
Shares Outstanding127.3M
P/E (TTM)29.80
Diluted EPS (TTM)$0.85
Enterprise Value$3.0B

Information as of 08/21/2026

Company Profile

$3.2B
Market Cap
$167.0M
Net Income
Sector: Healthcare
Industry: Health Information Services
500 3rd Street, San Francisco, CA, United States, 94107
650 549 4330

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Key Executives

  • Jeffrey A. Tangney
  • Siddharth Sitaram
  • John Vaughan
  • Perry Scott Gold
  • Steven L. Zatz

Current Ownership Distribution

  • Institutions2.0B (74.80%)
  • Mutual Funds636.2M (23.30%)
  • Insiders51.8M (1.90%)
  • Other0 (0.00%)